RENFLEXIS®

RENFLEXIS® (Infliximab-abda) a biosimilar to Remicade, is a drug used in the treatment of Inflammatory Bowel Disease, as well as other autoimmune diseases.

RENFLEXIS® is manufactured by Organon.

Administration and Dosage:

It is a weight-based medication following a recommended induction dose of 5mg/kg and maintenance dose of 10mg/kg (per Prescribing Doctor’s recommendation). The medication is infused intravenously in intervals at week 0, 2, 6 and then every 8 weeks for maintenance.

Common Side Effects:

The more common side effects of RENFLEXIS® include risk of infection.

More information:

Please read the full Prescribing Information and Medication Guide for RENFLEXIS® and discuss any questions you have with your doctor.

Indication:

RENFLEXIS® is indicated to treat:

  • Crohn’s Disease

  • Ulcerative Colitis

  • Pediatric Ulcerative Colitis

  • Pediatric Crohn’s Disease

  • Rheumatoid Arthritis

  • Ankylosing Spondylitis

  • Psoriatic Arthritis

  • Plaque Psoriasis

Contact Us

Interested in working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!

Check our Privacy Practice